An internal FDA memo has surfaced, revealing that at least 10 children may have lost their lives due to COVID-19 vaccinations. This isn’t some conspiracy theory from the fringes—it’s a sobering report straight from the U.S. Food and Drug Administration, as covered by the New York Times.
The Standard reported that on Friday, the New York Times dropped a bombshell story that uncovered the tragic link between these vaccinations and child deaths, with heart inflammation, or myocarditis, flagged as a potential culprit, while Health Secretary Robert F. Kennedy Jr. pushes sweeping policy changes to limit vaccine access.
This FDA memo, penned by the agency’s chief medical and scientific officer, Vinay Prasad, didn’t just drop a bombshell—it lit a fuse.
It lacks specifics on the children’s ages, health backgrounds, or even which vaccine brands were involved. That vagueness only fuels the fire of concern among parents and skeptics alike.
Myocarditis, a condition that can silently wreak havoc on young hearts, was named as a possible reason for these heartbreaking losses. For those of us who’ve long questioned the one-size-fits-all vaccine push, this is a grim validation of the risks that have too often been downplayed by bureaucrats.
Adding to the unease, the Department of Health and Human Services, which oversees the FDA, has stayed mum on the matter. When Reuters reached out for a statement, they got nothing but crickets. That silence speaks volumes about the discomfort this revelation has stirred in the halls of power.
Meanwhile, Health Secretary Robert F. Kennedy Jr., a man who’s been battling the vaccine establishment for years, isn’t waiting for apologies.
He’s already rolled out a policy restricting COVID shots to those 65 and older or with underlying health issues. It’s a bold move that’s sure to rile up the progressive health crowd who’ve treated these vaccines as gospel.
Kennedy, often painted as an anti-vaccine warrior, has a history of challenging the narrative, even linking shots to autism in past statements.
While the science on that claim remains contentious, his appointment as the nation’s top health official under President Donald Trump signals a seismic shift in how we approach immunization. His critics may scoff, but many Americans are ready for a fresh look at these policies.
Let’s not forget the context here: during Trump’s first term, as the COVID-19 crisis exploded, and later under President Joe Biden, health officials couldn’t stop singing the praises of these vaccines as lifesavers.
That unwavering cheerleading now feels tone-deaf in light of this memo. How many more risks were swept under the rug while the public was told to just “trust the science”?
Vinay Prasad, the FDA’s top medical mind, didn’t mince words about the gravity of this finding. “A profound revelation,” he called it, signaling that the agency is finally waking up to the need for stricter scrutiny. That’s a polite way of saying the system failed these kids—and it’s about time for accountability.
Prasad isn’t stopping at words; the memo outlines plans to tighten vaccine oversight with randomized studies across all subgroups.
If that had been in place sooner, might these 10 children still be with us? It’s a haunting question that demands answers, not more platitudes from the health elite.
For too long, the narrative around COVID vaccines has been a sacred cow, immune to criticism or even honest debate. Kennedy’s restrictions and the FDA’s new direction are a slap in the face to that dogma. And frankly, it’s a relief to see someone in charge willing to ask the hard questions, even if it upsets the status quo.
Yet, let’s be clear: this isn’t about vilifying vaccines or the people who believe in them. It’s about ensuring safety, especially for our children, who can’t speak for themselves when policies go wrong. Compassion for those grieving families must guide this conversation, not political point-scoring.
The lack of detail in the memo—no ages, no health conditions, no manufacturers named—feels like a dodge. Parents deserve transparency, not a half-baked report that raises more questions than it answers. If the FDA is serious about rebuilding trust, they’ve got to do better than this.
